|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123 JPY | 0.00% |
|
-3.15% | -8.89% |
| Apr. 01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
| Feb. 13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
Chiome Bioscience Inc. provided earnings guidance for 2023. For the period, the company expects net sales of ¥640 million in the drug discovery support business.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.89% | 43.53M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CHIOME BIOSCIENCE INC. 
